Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems?
Karako K, Song PP, Chen Y, Karako T
BioScience Trends. 2022; 16(6):381-385.
Focusing on development of novel sampling approaches and alternative therapies for COVID-19: Are they still useful in an era after the pandemic?
BioScience Trends. 2022; 16(6):386-388.
How do RNA binding proteins trigger liquid-liquid phase separation in human health and diseases?
Huai Y, Mao WJ, Wang XH, Lin X, Li Y, Chen ZH, Qian AR
BioScience Trends. 2022; 16(6):389-404.
An overview: Management of patients with advanced hepatocellular carcinoma
Wang JC, Wu R, Sun JY, Lei F, Tan H, Lu XJ
BioScience Trends. 2022; 16(6):405-425.
Timing of parathyroidectomy for kidney transplant patients with secondary hyperparathyroidism: A practical overview
Wang B, Li W, Wang Q, Zhang W
BioScience Trends. 2022; 16(6):426-433.
Longitudinal impact of compliance with routine CD4 monitoring on all cause deaths among treated people with HIV in China
Yin H, Ye R, Yang Y, Wang J, Tang R, Yao S, Duan S, Ding Y, He N
BioScience Trends. 2022; 16(6):434-443.
Thrombin cleaves recombinant soluble thrombomodulin into a lectin-like domain fragment and a fragment with protein C-activating cofactor activity
Yokoyama H, Tateishi K, Baba Y, Kobayashi A, Hashimoto M, Fukuda S, Yamao H, Maruyama T, Nakata M, Matsushita M
BioScience Trends. 2022; 16(6):444-446.
Can nasal irrigation with chlorine dioxide be considered as a potential alternative therapy for respiratory infectious diseases? The example of COVID-19
Cao J, Shi Y, Wen M, Peng Y, Miao Q, Liu X, Zheng M, Asakawa T, Lu H
BioScience Trends. 2022; 16(6):447-450.
Verification of the efficiency of saline gargle sampling for detection of the Omicron variant of SARS-CoV-2, a pilot study
Qiao K, Tao X, Liu H, Zheng M, Asakawa T, Lu H
BioScience Trends. 2022; 16(6):451-454.
Reflections on abortion rights: From policy to medicine
Chen S, Gu XL, Qi L, Qi Q, Zhou J, Wang L
BioScience Trends. 2022; 16(6):455-458.
Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19?
Li J, Yan YF, Dou FZ, Gao JJ
BioScience Trends. 2022; 16(6):459-461.